After the US Food and Drug Administration approval in 2002 of the first ever fully human mAb drug (AbbVie’s Humira (adalimumab)), fully human mAbs rapidly became the gold standard of mAb-based ...

I-Mab Biopharma (‘I-Mab’), headquartered in Shanghai, is different. From its inception in 2015, the company has been focused exclusively on discovering and developing innovative biologics ...

Programme will launch the implementation of the “Mangrove Restoration: Nature-Based Solutions in Biosphere Reserves of Latin America and the Caribbean” project (MangRes Project), thanks to the ...

In their new study, the researchers showed that mAb 3A6 helps block infection by binding to an important ... Ph.D., MBA, who led the recent Nature Communications study alongside John A. G. Briggs, ...